Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Lomitapide | 182431-12-5 | 99.6% | 693.72 | 25 MG
SDP

Catalog No. 5000363286
Encompass_Preferred

Lomitapide is a potent inhibitor of microsomal triglyceride-transfer protein (MTP), demonstrating an IC50 of 8 nM in vitro.

  • Inhibits microsomal triglyceride-transfer protein (MTP) with an IC50 of 8 nM in vitro.
  • Reduces plasma concentrations of low density lipoprotein cholesterol (LDL-C) and triglycerides.
  • Indicated for the treatment of Homozygous Familial Hypercholesterolemia (HoFH).
  • Metabolized via cytochrome P-450 (CYP) isoenzyme 3A4.
  • Bioavailability of 7.1% and a mean half-life of 39.7 hours for the 50-mg capsule.
  • Exhibits antiproliferative activity against human HepG2 cells.
  • Appears as a solid, white to off-white substance.

Catalog No. 50-003-63286 Supplier Medchemexpress LLC Supplier No. 25MGHY14667
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lomitapide is a potent inhibitor of microsomal triglyceride-transfer protein (MTP), demonstrating an IC50 of 8 nM in vitro.

  • Inhibits microsomal triglyceride-transfer protein (MTP) with an IC50 of 8 nM in vitro.
  • Reduces plasma concentrations of low density lipoprotein cholesterol (LDL-C) and triglycerides.
  • Indicated for the treatment of Homozygous Familial Hypercholesterolemia (HoFH).
  • Metabolized via cytochrome P-450 (CYP) isoenzyme 3A4.
  • Bioavailability of 7.1% and a mean half-life of 39.7 hours for the 50-mg capsule.
  • Exhibits antiproliferative activity against human HepG2 cells.
  • Appears as a solid, white to off-white substance.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.